Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

Abstract Oncogenic membrane receptor tyrosine kinases such as MET and EGFR, or auto-active variants thereof, are important targets for cancer precision therapy. Targeted inhibition of these oncogenic receptors however invariably leads to resistance, resulting from acquisition of resistance-inducing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Corina N. A. M. van den Heuvel, Arvid I. Das, Tessa de Bitter, Femke Simmer, Thomas Wurdinger, Miguel Angel Molina-Vila, William P. J. Leenders
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a96e3530439a41b7b9df6a5ba6233936
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a96e3530439a41b7b9df6a5ba6233936
record_format dspace
spelling oai:doaj.org-article:a96e3530439a41b7b9df6a5ba62339362021-12-02T15:09:09ZQuantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes10.1038/s41598-018-25328-52045-2322https://doaj.org/article/a96e3530439a41b7b9df6a5ba62339362018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25328-5https://doaj.org/toc/2045-2322Abstract Oncogenic membrane receptor tyrosine kinases such as MET and EGFR, or auto-active variants thereof, are important targets for cancer precision therapy. Targeted inhibition of these oncogenic receptors however invariably leads to resistance, resulting from acquisition of resistance-inducing mutations or from selective outgrowth of a priori resistant tumour cells. Most applied molecular protocols cannot distinguish between intracellular and intercellular heterogeneity of oncogene (variant) expression, which may lead to misinterpretation of the molecular make-up of a cancer and suboptimal application of targeted therapies. We here combined two related techniques to allow semiquantitative and localized in situ detection of specific transcript splice variants using single molecule molecular inversion probe (smMIP)-based next generation sequencing and padlock probe-based rolling circle amplification, respectively. We show highly specific padlock probe-based multiplex detection of MET, METΔ7-8 and METΔ14 transcripts, lacking exons 7–8 and exon 14 respectively, and of EGFR and the auto-active EGFRvIII, lacking exons 2–7. The combination of quantitative transcript variant detection with smMIPs and transcript localization using padlock probes can be used for detection of oncogenic transcripts on the single-cell level, allowing study of tumour heterogeneity. Visualization of tumour heterogeneity can shed light on the biology underlying drug resistance and potentially improve targeted therapeutics.Corina N. A. M. van den HeuvelArvid I. DasTessa de BitterFemke SimmerThomas WurdingerMiguel Angel Molina-VilaWilliam P. J. LeendersNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Corina N. A. M. van den Heuvel
Arvid I. Das
Tessa de Bitter
Femke Simmer
Thomas Wurdinger
Miguel Angel Molina-Vila
William P. J. Leenders
Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes
description Abstract Oncogenic membrane receptor tyrosine kinases such as MET and EGFR, or auto-active variants thereof, are important targets for cancer precision therapy. Targeted inhibition of these oncogenic receptors however invariably leads to resistance, resulting from acquisition of resistance-inducing mutations or from selective outgrowth of a priori resistant tumour cells. Most applied molecular protocols cannot distinguish between intracellular and intercellular heterogeneity of oncogene (variant) expression, which may lead to misinterpretation of the molecular make-up of a cancer and suboptimal application of targeted therapies. We here combined two related techniques to allow semiquantitative and localized in situ detection of specific transcript splice variants using single molecule molecular inversion probe (smMIP)-based next generation sequencing and padlock probe-based rolling circle amplification, respectively. We show highly specific padlock probe-based multiplex detection of MET, METΔ7-8 and METΔ14 transcripts, lacking exons 7–8 and exon 14 respectively, and of EGFR and the auto-active EGFRvIII, lacking exons 2–7. The combination of quantitative transcript variant detection with smMIPs and transcript localization using padlock probes can be used for detection of oncogenic transcripts on the single-cell level, allowing study of tumour heterogeneity. Visualization of tumour heterogeneity can shed light on the biology underlying drug resistance and potentially improve targeted therapeutics.
format article
author Corina N. A. M. van den Heuvel
Arvid I. Das
Tessa de Bitter
Femke Simmer
Thomas Wurdinger
Miguel Angel Molina-Vila
William P. J. Leenders
author_facet Corina N. A. M. van den Heuvel
Arvid I. Das
Tessa de Bitter
Femke Simmer
Thomas Wurdinger
Miguel Angel Molina-Vila
William P. J. Leenders
author_sort Corina N. A. M. van den Heuvel
title Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes
title_short Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes
title_full Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes
title_fullStr Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes
title_full_unstemmed Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes
title_sort quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/a96e3530439a41b7b9df6a5ba6233936
work_keys_str_mv AT corinanamvandenheuvel quantificationandlocalizationofoncogenicreceptortyrosinekinasevarianttranscriptsusingmolecularinversionprobes
AT arvididas quantificationandlocalizationofoncogenicreceptortyrosinekinasevarianttranscriptsusingmolecularinversionprobes
AT tessadebitter quantificationandlocalizationofoncogenicreceptortyrosinekinasevarianttranscriptsusingmolecularinversionprobes
AT femkesimmer quantificationandlocalizationofoncogenicreceptortyrosinekinasevarianttranscriptsusingmolecularinversionprobes
AT thomaswurdinger quantificationandlocalizationofoncogenicreceptortyrosinekinasevarianttranscriptsusingmolecularinversionprobes
AT miguelangelmolinavila quantificationandlocalizationofoncogenicreceptortyrosinekinasevarianttranscriptsusingmolecularinversionprobes
AT williampjleenders quantificationandlocalizationofoncogenicreceptortyrosinekinasevarianttranscriptsusingmolecularinversionprobes
_version_ 1718387893880225792